Alteration of the pharmacokinetics of COL-3, a matrix metalloproteinase inhibitor, due to acute gastrointestinal toxicity of doxorubicin. [electronic resource]
- Pharmaceutical research Nov 2005
- 1954-63 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0724-8741
10.1007/s11095-005-6096-4 doi
Acute Disease Animals Blood Proteins--metabolism Diarrhea--chemically induced Doxorubicin--pharmacokinetics Drug Interactions Gastrointestinal Tract--drug effects Male Matrix Metalloproteinase Inhibitors Protease Inhibitors--pharmacokinetics Protein Binding Rats Rats, Sprague-Dawley Tetracyclines--pharmacokinetics